A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David P Rosenbaum, Ph.D.
Ardelyx
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ardelyx Investigational Site
San Diego, California, United States
- Ardelyx Investigational Site
Jupiter, Florida, United States
- Ardelyx Investigational Site
Pinellas Park, Florida, United States
- Ardelyx Investigational Site
Rockford, Illinois, United States
- Ardelyx Investigational Site
Mission, Kansas, United States
- Ardelyx Investigational Site
Monroe, Louisiana, United States
- Ardelyx Investigational Site
Annapolis, Maryland, United States
- Ardelyx Investigational Site
Chesterfield, Michigan, United States
- Ardelyx Investigational Site
St Louis, Missouri, United States
- Ardelyx Investigational Site
Brooklyn, New York, United States
- Ardelyx Investigational Site
Greensboro, North Carolina, United States
- Ardelyx Investigational Site
Oklahoma City, Oklahoma, United States
- Ardelyx Investigational Site
Simpsonville, South Carolina, United States
- Ardelyx Investigational Site
Bristol, Tennessee, United States
- Ardelyx Investigational Site
Ogden, Utah, United States
- Ardelyx Investigational Site
Lynchburg, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2011
- Primary completion
- 31 Dec 2011
- Completion
- 29 Feb 2012
- Last update posted
- 15 Oct 2019
- Registered enrollment
- 186
- Registry id
- NCT01340053
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.